Moldova Pharmaceuticals and Healthcare Report Q2 2016

Date: March 16, 2016
Pages: 82
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M41E0D378A3EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Moldova's pharmaceutical market presents very limited opportunities for multinational drugmakers, in comparison to its neighbours in Eastern Europe. The country's small total market size and its reliance on out-of-pocket payments highlight the challenges it poses. Moldova's economic outlook, which is defined by its relations with Russia and the EU, will play a significant role in how the market grows over the coming years.

Headline Expenditure Projections
  • Pharmaceuticals: MDL5.83bn (USD310mn) in 2015 to MDL6.23bn (USD322mn) in 2016; 6.8% in local currency terms and 4.1% in US dollar terms.
  • Healthcare: MDL13.86bn (USD736mn) in 2015 to MDL14.80bn (USD765mn) in 2015; +6.8% in local currency terms and 4.0% in US dollar terms.
BMI Industry View
  Table: Headline Pharmaceuticals & Healthcare Forecasts (Moldova 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Moldova 2012-2020)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Moldova 2012-2020)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Moldova 2012-2020)
OTC Drug Market Forecast |
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Moldova 2012-2020)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Moldova 2014-2020)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Moldova 2014-2020)
Industry Risk Reward Index
Central And Eastern Europe Risk/Reward Index
Moldova Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
  Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Gedeon Richter
GlaxoSmithKline
Novartis (Sandoz)
Pfizer
Sanofi
Top Pharm
Demographic Forecast
  Table: Population Headline Indicators (Moldova 1990-2025)
  Table: Key Population Ratios (Moldova 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Moldova 1990-2025)
  Table: Population By Age Group (Moldova 1990-2025)
  Table: Population By Age Group % (Moldova 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Moldova Pharmaceuticals and Healthcare Report Q2 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: